Philip Heuzenroeder

AJ Park IP Pty Ltd. provides intellectual property services. Its services include identifying and protecting, strategy and commercialization, defending and enforcing. The company was founded in 1891 and is headquartered in Auckland, New Zealand.

AJ Park IP Pty Ltd. provides intellectual property services. Its services include identifying and protecting, strategy and commercialization, defending and enforcing. The company was founded in 1891 and is headquartered in Auckland, New Zealand.

AJ Park IP Pty Ltd. provides intellectual property services. Its services include identifying and protecting, strategy and commercialization, defending and enforcing. The company was founded in 1891 and is headquartered in Auckland, New Zealand.

Cure Brain Cancer Foundation is a non-profit organization based in Australia that is dedicated to funding innovative brain cancer research. The private company is based in Sydney, Australia. The foundation has invested over $30 million into brain cancer research, including clinical trials and pre-clinical research efforts across pediatric and adult brain cancers. The foundation passionately forges research collaborations, brings world-class clinical trials, and gives people with brain cancer greater access to innovative new treatments. The foundation's mission is to unite the community and rapidly increase brain cancer survival, improving the quality of life for people impacted by the disease, with a vision to ultimately find a cure for brain cancer. The Australian company was founded in 2001. Lance Kawaguchi has been the CEO of the company since 2021.

Cure Brain Cancer Foundation is a non-profit organization based in Australia that is dedicated to funding innovative brain cancer research. The private company is based in Sydney, Australia. The foundation has invested over $30 million into brain cancer research, including clinical trials and pre-clinical research efforts across pediatric and adult brain cancers. The foundation passionately forges research collaborations, brings world-class clinical trials, and gives people with brain cancer greater access to innovative new treatments. The foundation's mission is to unite the community and rapidly increase brain cancer survival, improving the quality of life for people impacted by the disease, with a vision to ultimately find a cure for brain cancer. The Australian company was founded in 2001. Lance Kawaguchi has been the CEO of the company since 2021.